Atlas Trials

Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients

Clinical trial NCT01825980 · COMPLETED

Trial details

NCT number
NCT01825980
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatitis C
Start date
2013-03-01
Primary completion
2014-12-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.